SQZB — SQZ Biotechnologies Co Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $1.18m
- -$9.01m
- $21.48m
Annual balance sheet for SQZ Biotechnologies Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 107 | 98.3 | 170 | 144 | 63.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.25 | 2.08 | 2.44 | 3.1 | 0.384 |
Prepaid Expenses | |||||
Total Current Assets | 109 | 102 | 177 | 151 | 68.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.43 | 48.2 | 52 | 72.9 | 29.4 |
Other Long Term Assets | |||||
Total Assets | 116 | 152 | 231 | 226 | 99.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 21.3 | 38.3 | 45.2 | 33.2 | 21.8 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 52.7 | 93.8 | 104 | 102 | 42.8 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 62.9 | 58.6 | 127 | 124 | 57.1 |
Total Liabilities & Shareholders' Equity | 116 | 152 | 231 | 226 | 99.9 |
Total Common Shares Outstanding |